Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane Meeting Abstract

  

Authors:	Scher, H. I.; Jendrisak, A.; Gill, A.; Barnett, E.; Gopalan, A.; Zaidi, S.; Benoliel, H.; Carbone, E.; Byun, J.; Schonhoft, J.; Wenstrup, R.
Abstract Title:	Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual Conference
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Language:	English
ACCESSION:	WOS:000560368302415
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.5572
Notes:	Meeting Abstract: 5572 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172984